Liquid Biopsies and the Status of Pancreatic Cancer Screening
Dr. Conan Kinsey discusses the usefulness of liquid biopsies for pancreatic cancer screening and early detection.
Dr. Conan Kinsey discusses the usefulness of liquid biopsies for pancreatic cancer screening and early detection.
The 2022 AACR meeting featured pancreatic cancer research in artificial intelligence, screening and earlier detection, and vaccines.
Three different liquid biopsy blood tests are under development or now available for pancreatic and other cancers.
Drs. Allyson Ocean and Ying-Hsiu Su lead a liquid biopsy pilot study looking for KRAS proteins in urine, to detect pancreatic cancer.
Dr. Minetta Liu is part of the team conducting a clinical trial to find biomarkers that will become an easy blood test for pancreatic cancer.
Trovagene is developing a liquid biopsy for pancreatic cancer patients, to allow doctors to test for cancer and track treatment response.
Marianne, a nurse, went to a hospital that specializes in cancer. A liquid biopsy will determine the next step in her treatment.
Dr. Bert Vogelstein and his team at Johns Hopkins are working with a blood test called a liquid biopsy, which tests cells for mutations related to cancer.